SunWay Biotech Co., LTD. (1271.TWO)
- Previous Close
59.70 - Open
60.90 - Bid --
- Ask --
- Day's Range
59.40 - 61.00 - 52 Week Range
48.65 - 115.55 - Volume
18,192 - Avg. Volume
112,248 - Market Cap (intraday)
3.617B - Beta (5Y Monthly) --
- PE Ratio (TTM)
30.56 - EPS (TTM)
1.96 - Earnings Date --
- Forward Dividend & Yield 0.98 (1.61%)
- Ex-Dividend Date Apr 11, 2024
- 1y Target Est
--
SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.
sunway.cc--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1271.TWO
View MorePerformance Overview: 1271.TWO
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1271.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1271.TWO
View MoreValuation Measures
Market Cap
3.62B
Enterprise Value
3.57B
Trailing P/E
30.56
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.74
Price/Book (mrq)
1.11
Enterprise Value/Revenue
3.68
Enterprise Value/EBITDA
15.45
Financial Highlights
Profitability and Income Statement
Profit Margin
12.22%
Return on Assets (ttm)
2.37%
Return on Equity (ttm)
3.67%
Revenue (ttm)
970.18M
Net Income Avi to Common (ttm)
118.57M
Diluted EPS (ttm)
1.96
Balance Sheet and Cash Flow
Total Cash (mrq)
293.7M
Total Debt/Equity (mrq)
7.47%
Levered Free Cash Flow (ttm)
4.33M